Pharmaceutical amiodarone composition for parenteral delivery
Patent 6143778 Issued on November 7, 2000. Estimated Expiration Date: March 13, 2018. Estimated Expiration Date is calculated based on simple USPTO term provisions. It does not account for terminal disclaimers, term adjustments, failure to pay maintenance fees, or other factors which might affect the term of a patent.
The invention relates to a pharmaceutical composition for parenteral administration, characterized in that it comprises:from 1.5 to 8% by weight of an active principle consisting of amiodarone or one of the pharmaceutically acceptable salts thereofa physiologically acceptable buffer solution capable of solubilizing the active principle and of maintaining the pH of the composition between 2.4 and 3.8a nonionic hydrophilic surfactant.
Gough et al., J. Cardiovasc. Pharamacol. (1982), 4(3), 375-80 (Abstract)
Ward et al., J. Parenter. Sci. Technol. (1993), 47(4), 161-5 (Abstract